GE HealthCare Technologies Inc. (GEHC)
| Market Cap | 27.56B -21.3% |
| Revenue (ttm) | 20.98B +6.0% |
| Net Income | 1.91B -12.6% |
| EPS | 4.17 -12.4% |
| Shares Out | 454.89M |
| PE Ratio | 14.53 |
| Forward PE | 12.08 |
| Dividend | $0.14 (0.23%) |
| Ex-Dividend Date | Jul 24, 2026 |
| Volume | 9,134,013 |
| Open | 62.47 |
| Previous Close | 61.96 |
| Day's Range | 60.20 - 62.75 |
| 52-Week Range | 58.75 - 89.77 |
| Beta | 0.84 |
| Analysts | Buy |
| Price Target | 79.33 (+30.95%) |
| Earnings Date | Jul 29, 2026 |
About GEHC
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, an... [Read more]
Financial Performance
In 2025, GEHC's revenue was $20.63 billion, an increase of 4.84% compared to the previous year's $19.67 billion. Earnings were $2.08 billion, an increase of 4.57%.
Financial StatementsAnalyst Summary
According to 19 analysts, the average rating for GEHC stock is "Buy." The 12-month stock price target is $79.33, which is an increase of 30.95% from the latest price.
News
GE HealthCare sees Q2 earnings growth above prior expectation
GE HealthCare (GEHC) said, “Today, the Company is also providing certain preliminary, unaudited results for the second quarter ending June 30, 2026. GE HealthCare expects to report year-over-year Reve...
Correction: GE HealthCare affirms 2026 adjusted EPS outlook of $4.80-$5.00
17:38 EDT Correction: GE HealthCare (GEHC) affirms 2026 adjusted EPS outlook of $4.80-$5.00
GE HealthCare affirms fiscal 2026 outlook provided on April 29
GE HealthCare (GEHC) said, “For the full-year 2026, the company reaffirms guidance provided on April 29, 2026. The Company will provide additional details when it reports complete second quarter resul...
GE HealthCare CFO to step down
GE HealthCare said on Thursday that its Chief Financial Officer Jay Saccaro will step down from his role to pursue an opportunity outside the medical technology industry.
GE HealthCare names George Newcomb interim CFO
GE HealthCare (GEHC) announced that Jay Saccaro will step down as Vice President and Chief Financial Officer for an expanded role outside of the medical technology industry. The Company has…
GE HealthCare announces CFO transition; reports preliminary second quarter 2026 financial results and reaffirms guidance reflecting business momentum
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced that Jay Saccaro will step down as Vice President and Chief Financial Officer for an expanded role outside of the medical technol...
GE HealthCare announces introduction of MIM Anyware
GE HealthCare (GEHC) announced the introduction of MIM Anyware, a remote access platform that provides secure, healthcare system-controlled access to imaging data through a web browser without requiri...
GE HealthCare introduces MIM Anyware to extend remote access to imaging data and optimize clinical collaboration
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the introduction of MIM Anyware™, a remote access platform that provides secure, healthcare system-controlled access to imaging d...
GE HealthCare price target lowered to $67 from $69 at UBS
UBS lowered the firm’s price target on GE HealthCare (GEHC) to $67 from $69 and keeps a Neutral rating on the shares.
Catholic Health and GE HealthCare announce 10-year, $500M partnership
Catholic Health and GE HealthCare (GEHC) announced a 10-year strategic partnership, known as a Care Alliance, valued at approximately $500M, to help expand access to advanced imaging, precision diagno...
Catholic Health and GE HealthCare partner to expand patient access across Long Island
ROCKVILLE CENTRE, N.Y.--(BUSINESS WIRE)--Catholic Health, an integrated health system located on Long Island, NY, and GE HealthCare (Nasdaq: GEHC) announced today a 10-year strategic partnership, know...
GE HealthCare price target lowered to $75 from $80 at BTIG
BTIG analyst Ryan Zimmerman lowered the firm’s price target on GE HealthCare (GEHC) to $75 from $80 and keeps a Buy rating on the shares as part of a broader…
GE HealthCare initiated with a Market Perform at BMO Capital
BMO Capital initiated coverage of GE HealthCare (GEHC) with a Market Perform rating and $70 price target The innovation assets are “real” and Flyrcado and Photonova Spectra are “genuine long-term…
GE HealthCare and Mayo Clinic collaborating in prostate cancer research
GE HealthCare (GEHC) and Mayo Clinic announced the MI-BET – Molecular Imaging Biomarker-Based End of Therapy Trial – research collaboration, a novel theranostics study designed to explore a more perso...
GE HealthCare and Mayo Clinic aim to advance personalized cancer treatment through new theranostics research collaboration
CHICAGO & ROCHESTER, Minn.--(BUSINESS WIRE)--GE HealthCare and Mayo Clinic today announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) research collaboration, a novel theranost...
GE HealthCare to announce second quarter 2026 results on July 29, 2026
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026. The GE HealthCare management team wi...
Citi adds ‘upside 90-day catalyst watch’ on GE HealthCare
Citi is adding an “upside 90-day catalyst watch” on GE HealthCare (GEHC) while keeping a Neutral rating on shares and raising the price target to $69 from $65. With investor…
GE HealthCare announces cash dividend for second quarter of 2026
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2026 pay...
GE HealthCare announced Allia platform upgrade pathways
GE HealthCare (GEHC) announced Allia platform upgrade pathways designed to help customers modernize select legacy Innova and Discovery Image Guiding Solutions systems. “Interventional care continues t...
GE HealthCare introduces Allia upgrade pathways designed to modernize existing interventional suites
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced Allia™ platform upgrade pathways designed to help customers modernize select legacy Innova™ and Discovery™ Image Guiding Solutions (IGS) systems...
GE HealthCare initiated with an Outperform at RBC Capital
RBC Capital initiated coverage of GE HealthCare (GEHC) with an Outperform rating and $80 price target The firm sees an attractive risk/reward at current share levels. The company’s increased research…
GE HealthCare advances enterprise imaging with cloud-enabled solutions
GE HealthCare (GEHC) will showcase its latest enterprise imaging solutions at the Society for Imaging Informatics in Medicine 2026 Annual Meeting in Pittsburgh, PA. GE HealthCare continues to accelera...
GE HealthCare advancing enterprise imaging with cloud-enabled solutions
CHICAGO--(BUSINESS WIRE)--GE HealthCare will showcase its latest enterprise imaging solutions at the Society for Imaging Informatics in Medicine (SIIM) 2026 Annual Meeting in Pittsburgh, PA. Medical i...
GE HealthCare receives 510k clearance from U.S. FDA for MIM Contour ProtegeAI+
GE HealthCare (GEHC) announced it has received 510(k) clearance from the United States Food and Drug Administration, FDA, for MIM Contour ProtegeAI+ 2.0, an AI-enabled auto-contouring software to assi...
GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour ProtégéAI+™ 2.0, an AI...